ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,080 | +34.3% | 524 | +78.2% | 0.00% | – |
Q2 2023 | $10,484 | +40.4% | 294 | 0.0% | 0.00% | – |
Q1 2023 | $7,468 | -37.4% | 294 | 0.0% | 0.00% | – |
Q4 2022 | $11,925 | +19.2% | 294 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | 0.0% | 294 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | -9.1% | 294 | +25.6% | 0.00% | – |
Q1 2022 | $11,000 | -47.6% | 234 | -27.6% | 0.00% | – |
Q4 2021 | $21,000 | +40.0% | 323 | +38.0% | 0.00% | – |
Q3 2021 | $15,000 | -21.1% | 234 | 0.0% | 0.00% | – |
Q2 2021 | $19,000 | +18.8% | 234 | 0.0% | 0.00% | – |
Q1 2021 | $16,000 | -11.1% | 234 | 0.0% | 0.00% | – |
Q4 2020 | $18,000 | +80.0% | 234 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 234 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +11.1% | 234 | -22.5% | 0.00% | – |
Q1 2020 | $9,000 | -40.0% | 302 | +29.1% | 0.00% | – |
Q4 2019 | $15,000 | +114.3% | 234 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | +250.0% | 234 | +185.4% | 0.00% | – |
Q1 2019 | $2,000 | – | 82 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |